MRI and PET/CT of patients with bone metastases from breast carcinoma

European Journal of Radiology

Volumn 81, Issue 1, 2012, Pages

  Grankvist, J ^a   Fisker, R ^a   Iyer, V ^a   Frund E T ^a   Simonsen, C ^a   Christensen, T ^a   Stenbygaard, L ^a   Ewertz, M ^b   Larsson, E M ^c  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bone; Computed tomography; Diffusion; Magnetic resonance; Metastases; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BONE METASTASIS; BREAST CARCINOMA; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

AGED; AGED, 80 AND OVER; BONE NEOPLASMS; BREAST NEOPLASMS; CARCINOMA; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84855564244     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2010.10.024     Document Type: Article

References (15)

1. Costelloe CM, Rohren EM, Madewell JE, et al. Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis. Lancet Oncol 2009;10(6):606-14.
2. Major PP, Cook RJ, Lipton A, Smith MR, Terpos E, Coleman RE. Natural history of malignant bone disease in breast cancer and the use of cumulative mean functions to measure skeletal morbidity. BMC Cancer 2009;9:272.
3. Engelhard K, Hollenbach HP, Wohlfart K, von Imhoff E, Fellner FA. Comparison of whole-body MRI with automatic moving table technique and bone scintigraphy for screening for bone metastases in patients with breast cancer. Eur Radiol 2004;14(1):99-105. (Pubitemid 38181060)
4. Lauenstein TC, Sharma P, Hughes T, Heberlein K, Tudorascu D, Martin DR. Evaluation of optimized inversion-recovery fat-suppression techniques for T2-weighted abdominal MR imaging. J Magn Reson Imaging 2008;27(6):1448-54. (Pubitemid 351770702)
5. Murtz P, Krautmacher C, Traber F, Gieseke J, Schild HH, Willinek WA. Diffusionweighted whole-body MR imaging with background body signal suppression: a feasibility study at 3.0 Tesla. Eur Radiol 2007;17(12):3031-7. (Pubitemid 350142327)
6. Li S, Sun F, Jin ZY, Xue HD, Li ML. Whole-body diffusion-weighted imaging: technical improvement and preliminary results. J Magn Reson Imaging 2007;26(4):1139-44. (Pubitemid 47548180)
7. Schmidt GP, Wintersperger B, Graser A, Baur-Melnyk A, Reiser MF, Schoenberg SO. High-resolution whole-body magnetic resonance imaging applications at 1.5 and 3 Tesla: a comparative study. Invest Radiol 2007;42(6):449-59. (Pubitemid 46788746)
8. Schmidt GP, Baur-Melnyk A, Haug A, et al. Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 Tesla compared to FDG-PET-CT. Eur J Radiol 2008;65(1):47-58.
9. Wilm BJ, Svensson J, Henning A, Pruessmann KP, Boesiger P, Kollias SS. Reduced field-of-view MRI using outer volume suppression for spinal cord diffusion imaging. Magn Reson Med 2007;57(3):625-30. (Pubitemid 46385875)
10. Schmidt GP, Reiser MF, Baur-Melnyk A. Whole-body MRI for the staging and follow-up of patients with metastasis. Eur J Radiol 2009;70(3):393-400.
11. Luboldt W, Kufer R, Blumstein N, et al. Prostate carcinoma: diffusion-weighted imaging as potential alternative to conventional MR and 11C-choline PET/CT for detection of bone metastases. Radiology 2008;249(3):1017-25.
12. Shapiro MD. MR imaging of the spine at 3 T. Magn Reson Imaging Clin N Am 2006;14(1):97-108.
13. Tateishi U, Gamez C, Dawood S, et al. Bone metastases in patients with metastatic breast cancer: morphologic and metabolic monitoring of response to systemic therapy with integrated PET/CT. Radiology 2008;249(1):389-90.
14. Juweid ME, Stroobants S, Hoekstra OS, et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol 2007;25(5):571-878 [epub 2007 January 22].
15. Schmidt GP, Schoenberg SO, Schmid R, et al. Screening for bone metastases: whole-body MRI using a 32-channel system versus dual-modality PET-CT. Eur Radiol 2007;17(4):939-49. (Pubitemid 46766875)